Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
39.05
-0.90 (-2.25%)
May 29, 2026, 1:30 PM CST
Market Cap3.00B +35.4%
Revenue (ttm)973.15M -24.5%
Net Income-160.56M
EPS-2.91
Shares Out 76.92M
PE Ration/a
Forward PEn/a
Dividend0.19 (0.49%)
Ex-Dividend DateJul 24, 2025
Volume584,023
Open40.45
Previous Close39.95
Day's Range38.95 - 40.45
52-Week Range24.20 - 40.85
Beta0.32
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About TPE:1762

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DMF or COS, and other API products. It also provides specialty API immunosuppressants, including mycophenolate mofetil, rapamycin, and tacrolimus; deriva... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 198
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1762
Full Company Profile

Financial Performance

Financial Statements